Neoplastic Brachial Plexopathy Treatment & Management

  • Author: Mark A Wren, MD, MPH; Chief Editor: Robert H Meier III, MD   more...
 
Updated: Jan 19, 2010
 

Rehabilitation Program

Physical Therapy

Early passive range of motion (PROM) of the upper limb is appropriate to prevent contracture. If there is preserved volitional motor function, active-assistive range of motion (AAROM) and active range of motion (AROM) exercises may be instituted. Progressive resistance exercises, when tolerated, can help to maintain as much strength as possible. The physical therapist should instruct the patient in a home exercise program to incorporate self-directed range of motion (ROM) and strengthening activities whenever possible.

Physical therapy modalities also may be warranted for assisting in pain reduction in patients with NBP. Electrical modalities for pain control, such as transcutaneous electrical nerve stimulation (TENS) or interferential current, are reasonable but are considered to be a relative contraindication when applied directly over a malignant neoplasm. Edema control measures (eg, retrograde massage, elevation, compressive garments) may be considered. A sling or splint can help the patient maintain a comfortable position and protect the affected limb. A sling also can reduce edema, retard shoulder subluxation, and reduce additional traction on the brachial plexus.

Occupational Therapy

See the Physical Therapy section above. Completing a home safety evaluation for patients with NBP and their families is important. The home evaluation should include use of compensatory strategies and adaptive equipment to improve the patient's functional abilities. For example, a patient who can no longer perform bimanual skills may benefit from a device to help manipulate buttons in order to dress independently. The occupational therapist can work with the patient and maximize his/her capabilities in performing activities of daily living (ADL). The occupational therapist also can engage the patient in a sensory and motor re-education program if there is impaired function in the hand.

Speech Therapy

Though not directly related to plexopathies, metastatic neoplasm also may alter communication, swallowing, or cognitive function, requiring a speech therapy consultation.

Recreational Therapy

Recreational therapy can help to maintain the patient's interest and skills by incorporating leisure time activities into the rehabilitation program.

Next

Medical Issues/Complications

For more severe lesions, an interdisciplinary approach may be most effective, including prescription of physical, occupational, and recreational therapies. Coordination of therapies, consultants, complications, and medications is needed.

Treatment often is difficult and may be palliative; chemotherapy and radiation therapy (up to 50% of patients obtain significant pain relief) are used if the tumor is sensitive to them. In the aforementioned investigation by Kamenova and colleagues (see Causes), 22 of the study's patients received BP treatment, aimed specifically at the locoregional metastases, with radiation therapy (8 patients) or endocrine treatment or chemotherapy (14 patients) initially being employed.[5] In 19 of these patients, partial or complete remission of pain and neurologic deficits, lasting a median period of 8 months, occurred.

As the disease progresses, adequate pain control is the most important goal as most patients succumb to neoplastic involvement of vital organs within a few years.

Previous
Next

Surgical Intervention

Several authorities advise referral of patients with NBP to surgeons with special expertise in treatment of NBP. Accurate diagnosis may prevent unnecessary surgery for carpal tunnel syndrome or thoracic outlet syndrome. Surgery usually is performed only for definite tissue diagnosis in secondary neoplasms. Primary tumors, like benign schwannomas, are encapsulated, permitting surgical excision without sacrificing adjacent nerves.

Most solitary neurofibromas can be resected without producing or increasing deficit, but this procedure is more difficult than excision of encapsulated tumors and usually requires magnification, intraoperative nerve action potential recording, and sometimes cable grafts. Some neurofibromas are "dumbbell tumors" that extend into the epidural space. Many benign tumors (including neurofibromas) can be removed without significant loss using surgical loupes or microscope and repetitive NAP recording. Plexiform neuromas are more difficult to remove because of extensive segments of nerve fiber involvement. Some elements may have to be sacrificed for pain control and to save the remainder of the plexus. In patients with severe intractable pain, dorsal rhizotomy, dorsal root entry zone surgery, or high contralateral percutaneous cordotomies can be considered. Amputation and other destructive procedures often are ineffective.

Previous
Next

Consultations

Most patients have a consulting oncologist, as well as an internist or family practitioner. Some patients may need an anesthesiologist or interventional physiatrist for injections, and some may have seen a neurologist, or less commonly, a neurosurgeon (for more drastic measures mentioned above). Consultation with a psychologist may be helpful in terms of emotional adjustment, pain control, and supportive counseling.

Previous
Next

Other Treatment

Paravertebral nerve blocks or other injection procedures may be indicated, depending on the location of the tumor(s). NBP often is widespread and is not amenable to application of selective blocks.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Mark A Wren, MD, MPH  Medical Director, Department of Physical Medicine and Rehabilitation, HealthSouth Rehabilitation Hospital of Texarkana

Mark A Wren, MD, MPH is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, American Medical Association, and Texas Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Robert J Kaplan, MD  James E Van Zandt VA Medical Center, Staff Physician, Department of Rehabilitation Medicine

Robert J Kaplan, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, Association of Academic Physiatrists, and Physiatric Association of Spine, Sports and Occupational Rehabilitation

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Michael T Andary, MD, MS  Residency Program Director, Professor, Department of Physical Medicine and Rehabilitation, Michigan State University College of Osteopathic Medicine

Michael T Andary, MD, MS is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, American Medical Association, and Association of Academic Physiatrists

Disclosure: allergan Honoraria Speaking and teaching; Pfizer Honoraria Speaking and teaching

Kelly L Allen, MD  Regional Medical Director, IMX-Medical Management Services

Disclosure: Nothing to disclose.

Chief Editor

Robert H Meier III, MD  Director, Amputee Services of America; Active Medical Staff, Presbyterian/St Luke's Hospital, Spalding Rehabilitation Hospital, Select Specialty Hospital; Consulting Staff, Kindred Hospital

Robert H Meier III, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation and Association of Academic Physiatrists

Disclosure: Nothing to disclose.

References
  1. Kim DH, Murovic JA, Tiel RL. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center. J Neurosurg. Feb 2005;102(2):246-55.

  2. Siqueira MG, Martins RS, Teixeira MJ. Management of brachial plexus region tumours and tumour-like conditions: relevant diagnostic and surgical features in a consecutive series of eighteen patients. Acta Neurochir (Wien). Sep 2009;151(9):1089-98. [Medline].

  3. Kori SH, Foley KM, Posner JB. Brachial plexus lesions in patients with cancer: 100 cases. Neurology. Jan 1981;31(1):45-50. [Medline].

  4. Killer HE, Hess K. Natural history of radiation-induced brachial plexopathy compared with surgically treated patients. J Neurol. Jul 1990;237(4):247-50.

  5. Kamenova B, Braverman AS, Schwartz M, et al. Effective treatment of the brachial plexus syndrome in breast cancer patients by early detection and control of loco-regional metastases with radiation or systemic therapy. Int J Clin Oncol. Jun 2009;14(3):219-24. [Medline].

  6. Gerevini S, Mandelli C, Cadioli M, Scotti G. Diagnostic value and surgical implications of the magnetic resonance imaging in the management of adult patients with brachial plexus pathologies. Surg Radiol Anat. Mar 2008;30(2):91-101. [Medline].

  7. Cross NE, Glantz MJ. Neurologic complications of radiation therapy. Neurol Clin. Feb 2003;21(1):249-77. [Medline].

  8. Dumitru D. Brachial plexopathy and proximal mononeuropathies. In: Electrodiagnostic Medicine. Philadelphia:. Hanley & Belfus Inc;1995:585-642.

  9. Harper CM Jr, Thomas JE, Cascino TL, Litchy WJ. Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG. Neurology. Apr 1989;39(4):502-6. [Medline].

  10. Hathaway PB, Mankoff DA, Maravilla KR, et al. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience. Radiology. Mar 1999;210(3):807-14. [Medline].

  11. Kline DG, Judice DJ. Operative management of selected brachial plexus lesions. J Neurosurg. May 1983;58(5):631-49.

  12. Lachance DH, O''Neill BP, Harper CM Jr, et al. Paraneoplastic brachial plexopathy in a patient with Hodgkin''s disease. Mayo Clin Proc. Jan 1991;66(1):97-101.

  13. Liang R, Kay R, Maisey MN. Brachial plexus infiltration by non-Hodgkin''s lymphoma. Br J Radiol. Nov 1985;58(695):1125-7. [Medline].

  14. Meador KJ, Richards B, Hunter S, et al. Bibrachial palsy due to paraneoplastic encephalomyelitis. South Med J. Aug 1989;82(8):1053-5. [Medline].

  15. Mukherji SK, Castillo M, Wagle AG. The brachial plexus. Seminars in Ultrasound, CT and MRI. Semin Ultrasound CT MR. Dec 1996;17(6):519-38. [Medline].

  16. Pierce SM, Recht A, Lingos TI, et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys. 1992;23(5):915-23. [Medline].

  17. Stewart JB. The brachial plexus. In: Focal Peripheral Neuropathies. New York, NY:. Raven Press Ltd;1993:111-140.

  18. Weber RJ. Rehabilitation issues in plexopathies. In: Physical Medicine and Rehabilitation. Philadelphia: WB Saunders Co:. 990-1001.

  19. Wilbourn AJ. Brachial plexus disorders. In: Peripheral Neuropathy, PDPTJE. Philadelphia:. WB Saunders Co;1993:911-50.

  20. Wilbourn AJ. Electrodiagnosis of plexopathies. Neurol Clin. Aug 1985;3(3):511-29. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.